Squarepoint Ops LLC Allovir, Inc. Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.68 - $2.39 $128,956 - $453,244	189,642 Added 198.59%	285,138 $193,000
Q2 2023 Aug 14, 2023	BUY	$3.17 - $5.82 $69,543 - $127,679	21,938 Added 29.82%	95,496 $324,000
Q1 2023 May 15, 2023	BUY	$3.94 - $7.05 $3,502 - $6,267	889 Added 1.22%	73,558 $289,000
Q4 2022 Feb 14, 2023	BUY	$4.7 - $9.98 $341,544 - $725,236	72,669 New	72,669 $372,000
Q2 2022 Aug 15, 2022	SELL	$3.26 - $7.06 $36,629 - $79,326	-11,236 Reduced 39.82%	16,980 $66,000
Q1 2022 May 16, 2022	BUY	$6.75 - $13.52 $87,237 - $174,732	12,924 Added 84.51%	28,216 $190,000
Q4 2021 Feb 14, 2022	BUY	$12.94 - $25.99 $197,878 - $397,439	15,292 New	15,292 $198,000
Q3 2021 Nov 15, 2021	SELL	$16.97 - $25.06 $370,760 - $547,510	-21,848 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.44 - $25.06 $424,725 - $547,510	21,848 New	21,848 $431,000

44.6M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $40.9M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.